Thermo Fisher Scientific Human ATG9A Synthetic Peptide
인간 ATG9A 단백질의 C-말단 18개 아미노산 서열에 해당하는 합성 펩타이드입니다. 항체 PA5-21043과 함께 블로킹 펩타이드로 사용 가능합니다. 자가포식 연구 및 단백질 타깃 검증에 적합하며, PBS 완충액에 0.1% BSA와 0.02% sodium azide가 포함되어 있습니다.
- 카탈로그번호
- PEP1157
- 판매단위
- pk
카탈로그
1개 옵션 · 카탈로그 번호를 클릭하면 복사됩니다Thermo Fisher Scientific · Thermo Fisher Scientific Human ATG9A Synthetic Peptide
Applications
Control (Ctrl)
- Assay-dependent
Blocking Assay (BLOCK)
- Assay-dependent
Product Specifications
| 항목 | 내용 |
|---|---|
| Species Reactivity | Human |
| Class | Synthetic |
| Type | Peptide |
| Conjugate | Unconjugated |
| Form | Liquid |
| Concentration | 200 µg/mL |
| Purification | Purified |
| Storage Buffer | PBS, pH 7.2, with 0.1% BSA |
| Contains | 0.02% sodium azide |
| Storage Conditions | -20°C |
Product Specific Information
This peptide corresponds to 18 amino acids near the carboxy terminus of human ATG9A.
PEP-1157 can be used as a blocking peptide with polyclonal antibody PA5-21043.
Target Information
Macroautophagy is the major inducible pathway for the general turnover of cytoplasmic constituents in eukaryotic cells. It is responsible for the degradation of active cytoplasmic enzymes and organelles during nutrient starvation.
Macroautophagy involves the formation of double-membrane bound autophagosomes which enclose the cytoplasmic constituents targeted for degradation. These autophagosomes fuse with the lysosome (or vacuole), releasing single-membrane bound autophagic bodies that are then degraded within the lysosome (or vacuole).
Apg9 plays a direct role in the formation of the cytoplasm-to-vacuole targeting and autophagic vesicles, possibly serving as a marker for a specialized compartment essential for these vesicle-mediated alternative targeting pathways.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
Thermo Fisher Scientific 상품 둘러보기
전체보기
문의
0개 · 배송·재고 문의는 실시간 상담이 빠릅니다아직 등록된 문의가 없어요.